There is growing evidence indicating that gut microbiota contributes to the 14 development of metabolic syndrome and Type 2 Diabetes (T2D). The most widely-15 used model for T2D research is the leptin deficient db/db mouse model. Yet, a 16 characterisation of the gut microbial composition in this model in relationship with 17 the metabolism is lacking. The objectives of this study were to identify metabolomics 18 and microbial modulations associated with T2D in the db/db mouse model. The 19 majority of microbial changes observed included an increase of Enterobacteriaceae 20
Hepatic Flavin-containing MonoOxygenases (FMOs) oxidize the TMAs into 1 TriMethylAmine-N-Oxide (TMAO) which is further excreted in urine. In a larger 2 scale, these methyl compounds are essential for epigenetic regulation and a number 3 of other crucial biochemical pathways. Thus, gut microbiota impact lipid 4 homeostasis by modulating hepatic metabolism through host access to methyl 5 donors (de Castro et al., 2013, Koeth et al., 2013 , Wang et al., 2011 2017, Mora-Ortiz and Claus, 2017). Finally, the gut microbiome was also found 7 associated with metabolic syndrome, particularly with obesity and diabetes 8 (Karagiannides and Pothoulakis, 2007 , Yang et al., 2019 , Aydin et al., 2018 . 9 Metabolic syndrome is characterised by the co-occurrence of various cardiovascular 10 risk factors, such as central obesity, dyslipidaemia, hypertension and raised blood 11 sugar promoted by insulin resistance (Huang, 2009 ). It ultimately leads to obesity, 12 cardiovascular diseases and Type 2 Diabetes (T2D). This last disease is a complex 13 metabolic disorder characterised by insulin resistance which currently affects 90% 14 of people diagnosed with diabetes (https://www.who.int/diabetes/en/). High 15 circulating blood sugar levels systematically disturb organs resulting in kidney failure, 16 nerve damage, blindness and development of cardiovascular diseases (Tai et al., 2015, 17 Amin et al., 2010 , Anavekar et al., 2004 , Trautner et al., 1997 . The rapid spread of 18 diabetes worldwide urges us to develop a better understanding of environmental 19 factors contributing to the onset and development of the disease which requires 20 validated models of T2D. 21 In the context of T2D, low microbiota diversity was previously linked with higher 22 prevalence of insulin resistant phenotypes and low grade inflammation, associated 23 with a reduction of microbial butyrate (Le Chatelier et al., 2013 , Cotillard et al., 2013 . 24 A low level of inflammation of visceral adipose tissue has been correlated with 25 insulin resistance and obesity, due to the link between transcripts implicated in 26 inflammatory control and the accumulation of macrophage crown-like structures 28 2019). Some mouse studies have suggested however that the direction of change is 29 the opposite, and it is insulin resistance which leads to inflammation (Shimobayashi 1 et al., 2018) . Regardless of the direction of change, this indicates a correlation 2 between the innate immune system and insulin resistance mechanism (Aydin et al., 3 2018). In keeping with these findings, we recently observed a drastic metabolic 4 modulation of the spleen in a mouse model of T2D (Mora-Ortiz et al., 2019). Despite 5 growing evidence indicating that gut microbiota is a contributing factor to the onset 6 and development of metabolic syndrome (a disorder originating from a 7 dysregulation of energy metabolism and storage), the detailed links with the gut 8 microbiota remain largely unknown. 9 One of the most widely-employed model for T2D investigation is the db/db 10 (BKS.Cg-Dock7<m> +/+ Lepr<db>/ J) mouse model. Yet, only a few studies 11 have looked at the gut microbiota of this model in association with metabolomics Ortiz et al., 2019). This study however, focussed on the metabolites from the host, 18 and we did not cover the metabolites derived from the gut microbiota. Yet, these 19 metabolites offer an invaluable window into the gut microbiota metabolic activity 20 and provide an important insight into their role in the development of T2D. Here, 21 we characterise for the first time the metabolic changes occurring in faeces over time 22 and in the caecum content at 22 weeks of age, and their links with gut microbiota. 23 Therefore, the objectives of this study were to i) evaluate gut microbiota metabolic 24 changes in the db/db mouse model and compare stability of their metabolic activity 25 over time, ii) characterise the gut microbiota at caecum level and iii) interrogate 26 potential interactions between microorganisms from caecum and the host 27 metabolism.
28
Material and methods: 29 Animal handling and sample collection 1 Four-week-old mice (females, n=8; males, n=4) from the line BKS.Cg-Dock7<m> 2 +/+ Lepr<db>/ J and their corresponding WT controls were bought from Charles 3 River Laboratories, Italy. These animals were randomly allocated into two 4 homogenous environments (according to their genotype, i.e. WT or db/db) and were 5 acclimatised during one week upon arrival mixing bedding. After acclimatization, 6 bedding was mixed on weekly basis according to the genetic background. Body 7 weight was also measured at the same frequency. Faecal samples were collected at 7, 8 8, 9, 10, 12, 13, 14, 18 and 22- week-old (Figure 1 .a). Caecum content was collected 9 at end point during dissection, and immediately frozen into liquid nitrogen. Animals 10 were euthanized by neck dislocation at week 22 in accordance with the regulations 11 of the United Kingdom Animals (Scientific Procedures) Act, 1986 (ASPA) and 12 approved by the Home Office (PPL 70/7942). 14 DNA from faecal and caecum content samples was extracted using GeneMATRIX Germany) equipped with a cooled SampleJet and a TCI CryoProbe from the same 11 company was used to obtain all NMR spectra for faecal and caecum content waters. 12 Standard 1D noesypr1d pulse sequences were used to acquire all one-dimensional 13 (1D) NMR spectra, with a mixing time of 10 ms. A total of 64 scans were stored 14 into 64 K data points; the spectral width was 13 ppm. Furthermore, 2D COSY 15 experiments were carried out in all matrices.
13

DNA extractions, sequencing and analysis
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Metabolomics data pre-processing and multivariate statistical analysis 17 MestReNova version 11.0.2-18153 (Mestrelab Research S.L., Spain) was used to pre-18 process all spectra. Baseline corrections were carried out using Whittaker smoother 19 algorithm and multipoint baseline correction when appropriate. Residual water (d 20 4.70-5.10) and noise (regions before d 0.5 and after d 9.5) were removed. Calibration 21 was done using TSP (d 0.00) as reference. The spectra were then imported into 22 Matlab version R2015b (Mathworks, UK) and analysed using Korrigan Toolbox Resonance data bank (BMRB, http://www.bmrb.wisc.edu) and published literature 13 were used to identify metabolites that were modulated. 15 bacterial abundance from caecum content 16 Bacterial abundance from caecum content (n=12) was correlated with 20 17 metabolomics' matrices including: caecum content (n=12), faecal content (n=8), 18 plasma (n=12), spleen (n=12), kidney (n=12), liver (n=6), muscle (n=12), heart 19 (n=12), hypothalamus (n=12), cerebrum (n=12), cerebellum (n=12), eye (n=12), 20 duodenum (n=12), jejunum (n=12), ileum (n=12), proximal colon (n=12), 21 transversal colon (n=12), distal colon (n=12), WAT apolar (n=12) and polar phase 22 (n=12) which were previously published (Mora-Ortiz et al., 2019). After a 23 preliminary screening, only those models whose Q2 was positive and overfit was 24 lower than 50% were considered for further analysis. 25 26 Results and discussion: 27 Previously, we published the metabolic and phenotypic profile of the same BKS.Cg- identified over 60 metabolites in total. Here, we study the metabolism of faeces and 2 caecum content, which was not previously described, and their relationship with gut 3 microbiota, to get new insights into changes in gut microbes' metabolic activity 4 during the development of T2D. The 16s rRNA sequencing analysis was carried out using Illumina MiSeq System 7 targeting the V3 and V4 regions at 22 weeks of age, when diabetes is fully established. 8 The rarefaction curve showed a total number of reads above 35,000 representing 9 85% of the total reads, which allowed an in-depth analysis of the microbiome ( Figure   10 1.b, top part). The alpha diversity analysis per genotype did not show significant 11 differences between groups (Figure 1 .b, bottom part). 12 A heat map constructed from the OTUs abundance table showed clear clustering of 13 diabetic individuals and controls. These clusters were principally driven by the 14 presence of Clostridiales, Bacteroides sp. and Bacteroidales in controls (Figure 1 .c). 15 Diabetic individuals had lower relative concentrations of Clostridiales than controls, 16 and higher levels of members from the family Enterobacteriaceae (Figure 1.d ). 17 Interestingly, Lactobacillus reuteri was four times higher in control individuals than in 18 diabetics. Previous studies have shown that L. reuteri is associated with reduced levels 19 of serum HbA1c and cholesterol in High-Fructose-Feed (HFD) rats, where it also 20 had reduced insulin resistance (Hsieh et al., 2018 , Hsieh et al., 2013 . 21 Commensal clostridia, a group found reduced in diabetic individuals, plays an 22 important role in gut homeostasis maintenance, producing butyrate that will be used Thus, unbalanced levels of Clostridia and Lactobacillus could be linked with a 27 dysfunctional gut microbiota among diabetic individuals, with potentially defective 28 gut homeostasis and frailty. 29 Previous studies proved that altered microbiota in T2D patients was associated with 1 reduction in butyrate-producing bacteria (such as Clostridiales sp., Eubacterium rectale, 2 F. prausnitzii and Roseburia amongst others) and increases in Lactobacillus species such 3 as Lactobacillus gasseri (Qin et al., 2012 , Karlsson et al., 2013 , and showed a significant The beta diversity analysis showed significant differences between both groups Porphyromonadaceae were significantly increased (p-values <0.01 *). In a previous 19 comparative study between db/db and ob/ob mouse gut microbiota, diabetic mice 20 had Dehalobacteriaceae and Enterobacteriaceae enriched compared to the ob/ob model 21 (Yang et al., 2019) , which indicates different modulations inherent to each model and 22 highlights the relevance to have model-specific microbial characterisations. 23 At genus level, the main changes occurred in the groups Dehalobacterium (p-24 value<0.001), which was decreased, and Parabacteroidetes (p-value<0.01), which was 25 increased amongst diabetic individuals. Increases in Parabacteroidetes were also 26 previously associated with high fat diet (Serino et al., 2012) . Linear discriminant 27 analysis Effect Size (LEfSe) results were consistent with the results described above. 28 Further details are provided in S1. 29 1 Fig. 1: a) Twelve mice were allocated into two different homogenous environments, 1 diabetic and control environment, according to their genetic background (db/db=6, 2 with females=4 and males= 2; control=6, with females=4 and males= 2). b) Top: 3 Alpha diversity rarefraction curve. Bottom: Alpha diversity violin boxplots grouped 4 by genotype. c) Heatmap with clusters for diabetics (top left) and control (top right). Metabolomics' NMR analysis of caecum and faeces 13 Faecal pellets were collected at regular intervals to observe time-related changes 14 concomitant with disease development. The O-PLS DA model using faecal waters 15 as independent variables, and time points and genetic background as dependant 16 variables (R 2 Ycum = 0.82 and a Q 2 Ycum = 0.34) showed quasi parallel trajectories, 17 indicating that irrespective of the weekly homogenisation of soil litters, the metabolic 18 shift associated with differences in genetic background remained constant. Diabetic 19 individuals had higher levels of several amino acids (aspartate, threonine, leucine, 20 BCAAs, histidine, phenylalanine and tyrosine), and lower levels of propionate and 21 acetate, indicating that the faecal microbiome of diabetic individuals had a higher 22 proteolytic and a lower saccharolytic activity (Figure 2 , left panels). Increased levels 23 of SCFAs were previously described associated to microbial fermentation of fibre in 
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O-PLS DA model correlating NMR spectra from tissues and biofluids with
11
The microbiota of both species is similar at phylum level, being dominated by 12 Bacteroidetes and Firmicutes, although we can also find differences here. For 13 example, the phylum Deferribacteres is common in the mouse intestinal system and 14 found very rarely in humans , Rawls et al., 2006 , Bik et al., 2006 . 15 Studies comparing humans and 3 different mouse strains concluded that despite 16 similarities in the profile between species, there are quantitative differences, despite 17 many bacteria are shared between human and mice (approximately 42% of the core 18 microbiome), only 4% of the genes are common in both species (Krych et al., 2013, 19 Xiao et al., 2015). These discrepancies in microbiome could be partially responsible 20 for the differences found in proteolysis, which is a feature to consider when 21 interpreting the microbial results from mouse studies. O-PLS DA models were built using bacterial abundance from caecum as predictors 11 and the metabolomics modulations as matrix of independent values. 12 In average, 36.8 bacteria per tissue and/or biofluid were found modulated and 13 potentially involved in diabetes, with a standard deviation of 13.6 units. The tissues 14 with lower number of valid O-PLS DA model was ileum, this could be due to a 15 lower number of metabolic modulations in this tissue associated with diabetes (S2).
16
Brain was the tissue with higher number of valid O-PLS DA models, with 62 models in total, however, it was overcome by liver when the R 2 threshold was set up to 0.75. 1 This could indicate that liver, possibly through its BAs interactions with gut 2 microbiota is one of the main organs affected by the shift in microbiome (Figure 4 3 and S3). Interestingly, liver connexion with gut microbiota was mainly dominated by 4 interactions with Bacteroidales, while brain and hypothalamus mainly linked mostly 5 with Clostridiales (see figure 4 and S3). 6 Gut-Brain Axis (GBA) is also an area of particular interest in T2D research. GBA 
12
Some of the most relevant bacteria involved in metabolomics interactions with 13 tissues were Lactobacillus, Bacteroidales S24-7, Parabacteroides gordonii, Mucispirillum 14 schaedleri, and Enterobacteriaceae, which had valid O-PLS DA models for metabolic 15 interactions with spleen, kidney, liver, muscle and heart. The last two bacterial taxa 16 were also associated with metabolic interactions in plasma. In the case of gut content 17 (faeces and caecum content), only Erysipelotrichaceae and Bacteroidales S24-7 were 18 common to both matrices. 19 Erysipelotrichaceae was again relevant in the GBA, and also Bacteroidales S24-7, Clostridiales and Mollicutes produced valid O-PLS DA models. 25 In total, 18 bacteria were found associated with metabolic perturbations in clusters 26 of tissues or biofluids (note, eye was not considered in this summary, for more 27 information about eye metabolic modulations linked to bacteria abundance see S2). 28 More details about the models are provided in the heat maps of the supplements S4 1 and S5. 
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